Allander Biotechnologies is a biotech company at the R&D stage focusing on drug development for unmet medical needs in tissue regeneration.
Allander Biotechnologies has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in October 2023.
Allander Biotechnologies is headquartered in Aurora, United States.
Allander Biotechnologies is a biotech company at the R&D stage focusing on drug development for unmet medical needs in tissue regeneration.
Allander Biotechnologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Allander Biotechnologies — Funding & Investors." VCBacked, October 11, 2023, https://www.vcbacked.co/company/allander-biotechnologies. Accessed August 1, 2026.
VCBacked. (2023). Allander Biotechnologies — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/allander-biotechnologies
{{cite web |title=Allander Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/allander-biotechnologies |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated